Viral vectors are the most efficient tools for gene delivery, and the search for tissue-specific infecting viruses is important for the development of in vivo gene therapy strategies. The baculovirus Autographa californica nuclear polyhedrosis virus is widely used as a vector for expression of foreign genes in insect cells, and its host specificity is supposed to be restricted to arthropods. Here we demonstrate that recombinant A. californica nuclear polyhedrosis virus is efficiently taken up by human hepatocytes via an endosomal pathway. High-level reporter gene expression from heterologous promoters was observed in human and rabbit hepatocytes in vitro. Mouse hepatocytes and some other epithelial cell types are targeted at a considerably lower rate. The efficiency of gene transfer by baculovirus considerably exceeds that obtained by calcium phosphate or lipid transfection. These properties of baculovirus suggest a use for it as a vector for liver-directed gene transfer but highlight a potential risk in handling certain recombinant baculoviruses.
Gene therapy is a powerful concept for the treatment of a variety of diseases (1) (2) (3) . The liver is the organ where many genetic diseases are manifested (4) . The first clinical trial for the treatment of familial hypercholesterolemia was based on transfer of the low density lipoprotein receptor gene to hepatocytes in vitro and subsequent retransplantation (5) . Since this protocol is very complicated and probably does not result in sufficient therapeutic effects, it would be particularly important to have methods available that allow for gene transfer to the liver in vivo (6, 7) . Retroviruses integrate their genome into that of the host cell but only in dividing cells (8) ; therefore, gene transfer to the liver requires stimulation of cell proliferation-e.g., by partial hepatectomy (9) (10) (11) . Adenoviral vectors deliver genes to the liver at very high efficiencies, approaching 100% gene transduction to hepatocytes (12) . However, the major disadvantage of this type of vector is the instability of the transferred genes in the target cells due to a lack of integration and to immunological response (13) . Recent modifications of the adenoviral viral vector system leading to a reduction of the immune response resulted in a significant prolongation of function of the transferred gene (14) . The general disadvantage of viral vectors available so far for gene delivery to the liver is their lack of organ specificity.
Alternative means for gene targeting to the liver have been developed, which are based on the concept of receptor targeting (15) (16) (17) (18) (19) (20) (21) . Despite the fact that the generation of particles for receptor targeting has been optimized recently and a remarkable efficiency of in vivo gene transfer could be achieved (22) , this is still not efficient enough for therapeutic application. Thus, it would be important to investigate the abilities of other viruses with regard to hepatocyte-specific gene delivery.
The baculovirusAutographa californica nuclear polyhedrosis virus (AcNPV), which is used as a vector for protein overproduction in insect cells (23) (24) (25) , was also studied in the past regarding its ability to infect mammalian cells (26) (27) (28) (29) . Abortive infection of some cell types by AcNPV has been detected, but neither gene expression nor viral DNA replication could be observed, most likely due to the restriction of viral promoter function to insect cells. These results suggested that the virus would not be a risk factor for humans and even prompted the development of baculovirus vectors as a biological weapon against particular insects. Recently, a baculovirus expressing an insect-specific toxin has been used in a field trial (30) .
As infection of liver cells by AcNPV was not tested before, we designed recombinant baculoviruses that should express reporter genes provided the virus is taken up by hepatocytes. The results described in this report favor the use of baculovirus vectors for the development of strategies for liver-directed gene therapy but also point at a requirement for a careful investigation of the potential risks connected with the unrestricted use of this type of virus.
MATERIALS AND METHODS
Generation of Recombinant Baculoviruses. Recombinant baculoviruses were constructed using the transfer vector pVL1392 (31) (PharMingen). For AcNPV-PHTag the gene coding for a C-terminally truncated simian virus 40 (SV40) large tumor antigen (T antigen) (32) was cloned next to the viral polyhedrin (PH) promoter, whereas for AcNPV-CMVTag this gene was fused to the cytomegalovirus (CMV) immediate early promoter (33) and inserted into pVL1392 in the orientation opposite to the PH promoter. The Photinus pyralis luciferase reporter gene (34) Assays for f3-galactosidase activity were carried out using the GalactoLight kit (Tropix, Bedford, MA) essentially as described by the manufacturer.
RESULTS
Baculovirus Infection of Hepatocytes. To explore the possibility that a recombinant baculovirus might be used to infect human hepatocytes, we constructed recombinant baculoviruses with the gene coding for a truncated large T antigen of SV40 under the control of either the PH gene promoter of baculovirus or the immediate early promoter of CMV. After incubation of human hepatocellular carcinoma cells (Huh7) for 1 h with the virus at a moi of 1000, T antigen was visualized by immunofluorescence. Whereas nuclei of hepatocytes treated with AcNPV-PHTag were negative, those treated with AcNPV-CMVTag were strongly positive (Fig. 1) . The efficiency of obtaining T antigen-positive nuclei by treatment of Huh7 cells with the latter virus was usually 80-100% at a moi 1000 and still "50% at a moi of 100. The actual uptake of both types of recombinant baculoviruses was confirmed by electron microscopy (Fig. 2) .
Specific Uptake by Hepatocytes. To investigate the specificity of hepatocyte infection by baculovirus, we tested different hepatic and nonhepatic cell types for expression of the luciferase reporter gene. We could not detect luciferase activity in human or mouse hepatocytes or NIH 3T3 fibroblast cells on infection by AcNPV-PHL, whereas high levels of activity were found in Sf9 insect cells, which shows that the PH promoter is inactive in the mammalian cells tested (Fig. 3a) . However, if expression was driven by the CMV promoter, high levels of luciferase activity were detected in various hepatic cell types (Fig. 3b) . In contrast, no or very low levels of expression were found in five lymphocytic cell lines, human and rodent carcinoma lines of different tissue origin (lung, breast, kidney, and bladder), mouse fibroblasts, and various neuronal cells (Fig. 3b) ducibly expressed one order of magnitude higher levels of luciferase than the hepatoblastoma line HepG2 or primary human hepatocytes, which, in turn, expressed almost 10-fold higher levels than primary or established mouse hepatocytes. Expression levels in rabbit primary hepatocytes were normally slightly higher than those in human primary hepatocytes.
Human liver sinusoidal endothelial cells also express some luciferase activity (Fig. 3b) .
Mode of Baculovirus Uptake by Hepatocytes. Since uptake of baculovirus by hepatocytes appeared to be strikingly efficient and specific, we investigated the mechanism of uptake in more detail. Treatment of Huh7 cells with AcNPV-CMVL, tested at different moi, produced a clear dose-response curve (Fig. 4a) , suggesting a saturable receptor-mediated uptake of the virus. Competition experiments (Fig. 4b) were carried out in these cells using a constant amount of the expressing virus AcNPV-CMVL (moi of 50) and increasing amounts of the nonexpressed virus AcNPV-PHL. Both monolayers and freshly trypsinized cells were infected. At a ratio of AcNPV-CMVL to AcNPV-PHL (moi) of 1:15 (total moi of 800), there was no competition for the expressing virus in cells in the monolayer; some competition was, however, observed at higher ratios (1:30) . However, in the trypsin-treated cells, competition was effective at lower ratios (above 1:3), suggesting that the number of receptors for the virus had been considerably reduced. Chloroquine had a very strong effect on luciferase expression (Fig. 4c) , suggesting that endosomal maturation is required for transport of the virus as was shown previously for insect cells (45). Efficiency of Gene Transfer into Hepatocytes. To gain some insight into the efficiency of gene transfer by a baculovirusderived vector, a comparative study was carried out in Huh7 cells including calcium phosphate transfection, lipid transfection (lipofection), and adenoviral vector infection. The ,B-ga- (40) did not show significant uptake of luciferaseexpressing virus (see Fig. 3b) 
